Pistoia Alliance Partners with Matador to Enable Greater Pharma R&D Collaboration in Japan
The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has announced a new partnership with Matador Japan KK , experts in the Japanese pharmaceutical sector, to enable pre-competitive collaboration in the Japanese market. The Alliance and Matador share the vision that bringing together experts from diverse backgrounds and experiences will […]
Novo Nordisk Invests $2B to Expand API Manufacturing in Denmark
Novo Nordisk will invest $2 billion starting in 2023 to expand an existing Active Pharmaceutical Ingredient (API) production facility in Hillerød, Denmark to support its future portfolio in serious chronic diseases. The facility will create additional production capacity and increase its ability to meet future market demands for its late-phase product portfolio. Construction is underway […]
SK pharmteco Doubles Viral Vector Production Capacity in Europe
SK pharmteco, SK Inc.’s contract development manufacturing organization (CDMO) for pharmaceuticals, completed its second facility for cell and gen e therapies (CGT) manufacturing in Europe. With this milestone, SK pharmteco is rapidly expanding its presence in the global market. SK pharmteco announced on June 22nd that Yposkesi, its commercial viral vector manufacturing subsidiary for CGTs […]
Digital Tech Gaining Ground In Boosting Women Healthcare
Women’s health has often been overlooked despite involving 50% of the population. However, there is growing recognition of the differences in health needs and outcomes between men and women. Scientific breakthroughs, new technologies, and policies provide unique opportunities to improve women’s health and reduce societal and economic costs. In our digital era, data holds immense […]
Croda announces two new partnerships to drive sustainable delivery systems for the pharmaceutical industry
Croda International Plc (Croda) announced that it has signed two new partnership agreements that will help the pharmaceutical industry move towards a more sustainable supply chain for vaccine adjuvants. The first partnership is an exclusive license agreement with Amyris, a leading synthetic biology company, for the supply of biotechnology-derived, pharmaceutical grade squalene used in adjuvants […]
Sygnature Discovery launches its LPS in vivo model to profile early – stage anti-inflammatory drugs
Sygnature Discovery has established an in vivo LPS model of inflammation which can help understand life-limiting neuroinflammatory conditions like Parkinson’s disease, multiple sclerosis, Alzheimer’s disease, and traumatic brain injuries and identify new drug targets. The LPS in vivo model supports early-stage anti-inflammatory drug discovery in neuroinflammation, kidney, and systemic inflammation. The inclusion of kidney inflammation […]
CluePoints, Ken Getz & Tufts CSDD and PwC Unveil New RBQM Insights Report at DIA Global Annual Meeting 2023
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, will share a first look at industry research at the DIA Global Annual Meeting 2023. CluePoints will host an exclusive opportunity for RBQM experts to be among the first to hear about the comprehensive use of Risk-Based Quality […]
DISCOVERING EFFECTIVE MEANS OF ADVANCING THE CLINICAL TRIALS ARENA
In this Q&A session with Dr. Christina Brennan, Senior Vice President for Clinical Research at Northwell Health, we learn about the benefits of Greenphire’s ClinCard in simplifying and automating patient reimbursements. Furthermore, she highlights the importance of implementing a more creative strategy for conducting clinical trials and investigating ways to improve their availability to potential […]
Rising Demand Fuels Asia Pacific Pharmaceutical CDMO Market
The Asia Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) market is expected to see significant growth. Factors driving this include rising pharmaceutical demand, increased focus on research and development, and the outsourcing of drug development and manufacturing. The market is projected to reach US$ 140.03B by 2031, with a CAGR of 9.9% from 2023 […]
Paper To Pixels: Digital Transformation In Life Sciences
To gain a competitive advantage, organizations are proactively overhauling their digital transformation strategies. It has become evident that traditional paper-based operations and fragmented data collection methods limit their ability to adapt and thrive in the constantly shifting market. The pandemic forced standard practices to change. The capacity to collect, aggregate, and analyze data is now […]
